Recently, in a coronavirus disease 2019 (COVID-19) study, PTL served as a herbal candidate for COVID-19 clinical evaluation by reducing cytokines, including IL-1, IL-2, IL-8, and TNF-α, and inhibiting inflammatory signaling pathways (39). This evidence concerns the gene IL2 and glycogen storage disease VI.